Oncostatin M Receptor Antikörper (Cy3)
Kurzübersicht für Oncostatin M Receptor Antikörper (Cy3) (ABIN709619)
Target
Alle Oncostatin M Receptor (OSMR) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human Oncostatin-M receptor
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- IF(IHC-P)(1:50-200)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- Oncostatin M Receptor (OSMR)
-
Andere Bezeichnung
- Osmr
-
Hintergrund
-
Synonyms: Oncostatin M receptor, Oncostatin M specic receptor subunit beta, Interleukin-31 receptor subunit beta, IL-31 receptor subunit beta, IL-31R subunit beta, IL-31R-beta, IL-31RB, Oncostatin-M-specic receptor, beta, OSMRB, MGC140467, MGC150626, MGC150627, MGC75127.
Background: Oncostatin M is a member of the IL6 family of cytokines. Functional receptors for IL6 family cytokines are multisubunit complexes involving members of the hematopoietin receptor superfamily. Many IL6 cytokines utilize gp130 as a common receptor subunit. OSM binds to the gp130 receptor subunit and, in association with the leukemia inhibitory factor receptor, induces a proliferative response in permissive cells. OSMR is an alternative subunit (for an OSM receptor complex (a heterodimer of gp130 and OSMR) that is activated by OSM but not by LIF.
-
Gen-ID
- 157869
-
Pathways
- JAK-STAT Signalweg, Growth Factor Binding
Target
-